New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
16:36 EDTBAXBaxter announces recall of parenteral nutrition products
Baxter announced it has initiated a voluntary recall in the United States of two lots of Clinimix and one lot of Clinimix E Injection parenteral nutrition products to the user level due to complaints of particulate matter found in the products. If infused, particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack, or damage to other organs such as the kidney or liver, the company said. There is also the possibility of allergic reactions, local irritation, and inflammation in tissues and organs, Baxter added. "There have been no reported adverse events associated with this issue to date, and the root cause of this voluntary recall has been identified and resolved," it stated. The recall is being conducted with the knowledge of the FDA.
News For BAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 7, 2015
07:36 EDTBAXInfectious Diseases Society of America to hold a conference
Subscribe for More Information
September 30, 2015
09:29 EDTBAXBaxter agrees to add Third Point representative to board
Subscribe for More Information
09:24 EDTBAXThird Point reaches standstill pact with Baxter, reports 9.9% stake
09:02 EDTBAXBaxter appoints Munib Islam to board; announces agreement with Third Point
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use